Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border population

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 85, Issue 6, 2009, Pages 574-581

  Felkner, Marilyn ^a,d   Suarez, Lucina ^a   Canfield, Mark A ^a   Brender, Jean D ^b   Sun, Qin ^c  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Folic acid; Homocysteine; Mexican Americans; Neural tube defects; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; MEXICO; NEURAL TUBE DEFECT; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; UNITED STATES; VITAMIN BLOOD LEVEL;

ERYTHROCYTES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MEXICO; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TEXAS; VITAMIN B 12;

EID: 67649376626     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20545     Document Type: Article

References (45)

1. Botto LD, Moore CA, Khoury MJ, Erickson JD. 1999. Neural-tube defects. N Engl J Med 341:1509-1519. (Pubitemid 29526355)
2. Brender J, Suarez L, Hendricks K, et al. 2002. Parental occupation and neural tube defect-affected pregnancies among Mexican Americans. J Occup Environ Med 44:650-656. (Pubitemid 34764979)
3. Brender JD, Olive JM, Felkner M, et al. 2004. Dietary nitrites and nitrates, nitrosatable drugs, and neural tube defects. Epidemiology 15:330-336. (Pubitemid 40416953)
4. Canfield MA, Collins JS, Botto LD, et al. 2005. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 73:679-689. (Pubitemid 41572010)
5. Christensen B, Arbour L, Tran P, et al. 1999. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84:151-157. (Pubitemid 29201082)
6. Cikot RJLM, Steegers-Theunissen RPM, Thomas CMG, et al. 2001. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr; 85:49-58. (Pubitemid 32156580)
7. Dunlevy LPE, Chitty LS, Burren KA, et al. 2007. Abnormal folate metabolism in foetuses affected by neural tube defects. Brain 130:1043-1049. (Pubitemid 47355603)
8. Economides DL, Ferguson J, Mackenzie IZ, et al. 1992. Folate and vitamin- B12 concentrations in maternal and fetal blood and amniotic-fluid in 2nd trimester pregnancies complicated by neural-tube defects. Br J Obstet Gynaecol 99:23-25.
9. Felkner M, Hendricks K, Suarez L, Waller DK. 2003. Diarrhea: a new risk factor for neural tube defects? Birth Defects Res A Clin Mol Teratol 67:504-508.
10. Gaber KR, Farag MK, Soliman SET, et al. 2007. Maternal vitamin B-12 and the risk of fetal neural tube defects in Egyptian patients. Clin Lab 53:69-75. (Pubitemid 46350985)
11. Hendricks KA, Nuno OM, Suarez L, Larsen R. 2001. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 12:630-635. (Pubitemid 33134523)
12. Hendricks KA, Simpson JS, Larsen RD. 1999. Neural tube defects along the Texas-Mexico border, 1993-1995. Am J Epidemiology 149:1119-1127. (Pubitemid 29270325)
13. Herrmann W, Herrmann M, Obeid R. 2007. Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 8: 17-31. (Pubitemid 46043889)
14. Honein MA, Paulozzi LJ, Mathews TJ, et al. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. J Am Med Assoc 285:2981-2986. (Pubitemid 32550116)
15. House JD, March SB, Ratnam S, et al. 2006. Improvements in the status of folate and cobalamin in pregnant Newfoundland women are consistent with observed reductions in the incidence of neural tube defects. Can J Public Health 97:132-135.
16. Kirke PN, Molloy AM, Daly LE, et al. 1993. Maternal plasma folate and vitamin-B12 are independent risk-factors for neural-tube defects. Q J Med 86:703-708. (Pubitemid 2001377)
17. Klee GG. 2000. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs. vitamin B-12 and folate. Clin Chem 46:1277-1283. (Pubitemid 30643299)
18. Mills JL, McPartlin JM, Kirke PN, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
19. Missmer SA, Suarez L, Felkner M, et al. 2006. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect 114:237-241. (Pubitemid 43193645)
20. Molloy AM, Kirke P, Hillary I, et al. 1985. Maternal serum folate and vitamin-B12 concentrations in pregnancies associated with neural-tube defects. Arch Dis Child 60:660-665. (Pubitemid 15013438)
21. Neuhouser ML, Beresford SAA, Hickok DE, Monsen ER. 1998. Absorption dietary and supplemental folate in women with prior pregnancies with neural tube defects and controls. J Am Coll Nutr 17:625-630. (Pubitemid 28546154)
22. Oh RC, Brown DL. Vitamin B-12 deficiency. 2003. Am Fam Physician 67:979-986.
23. Pfeiffer CM, Caudill SP, Gunter EW, et al. 2005. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr; 82:442-450.
24. Pfeiffer CM, Osterloh JD, Kennedy-Stephenson J, et al. 2008. Trends in circulating concentrations of total homocysteine among US adolescents and adults: findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Survey. Clin Chem 54:801-813.
25. Schorah CJ, Smithells RW, Scott J. 1980. Vitamin-B12 and anencephaly. Lancet 1:880.
26. Snow CF. 1999. Laboratory diagnosis of vitamin B-12 and folate deficiency: a guide for the primary care physician. Arch Intern Med 159:1289-1298. (Pubitemid 29293591)
27. Steegers-Theunissen RP, Boers GH, Blom HJ, et al. 1995. Neural-tube defects and elevated homocysteine levels in amniotic-fluid. Am J Obstet Gynecol 172:1436-1441.
28. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. 1994. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43:1475-1480.
29. Stoll C, Dott B, Alembik Y, Koehl C. Maternal trace elements, vitamin B12, vitamin A, folic acid, and fetal malformations. 1999. Reprod Toxicol 13:53-57. (Pubitemid 29122176)
30. Suarez L, Cardarelli K, Hendricks K. 2003a. Maternal stress, social support, and risk of neural tube defects among Mexican Americans. Epidemiology 14:612-616. (Pubitemid 40417042)
31. Suarez L, Gilani Z, Felkner M, et al. 2005. Exposure to polychlorinated biphenyls and risk of neural-tube defects in a Mexican American population. Int J Occup Environ Health 11:233-237. (Pubitemid 41061113)
32. Suarez L, Hendricks KA, Cooper SP, et al. 2000. Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate. Am J Epidemiol; 152:1017-1023.
33. Suarez L, Hendricks K, Felkner M, Gunter E. 2003b. Maternal serum B-12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol 13:81-88. (Pubitemid 36143706)
34. Taparia S, Gelineau-van Waes J, Rosenquist TH, Finnell RH. 2007. Importance of folate-homocysteine homeostasis during early embryonic development. Clin Chem Lab Med; 45:1717-1727. (Pubitemid 350232973)
35. Thorand B, Pietrzik K, Prinz-Langenohl R, et al. 1996. Maternal and fetal serum and red blood cell folate and vitamin B-12 concentrations in pregnancies affected by neural tube defects. Z Geburtshilfe Neonatol 200:176-180. (Pubitemid 26378708)
36. Toohey JI. 2008. Homocysteine toxicity in connective tissue: theories, old and new. Connect Tissue Res 49:57-61.
37. vanderPut NMJ, Thomas CMG, Eskes TK, et al. 1997. Altered folate and vitamin B-12 metabolism in families with spina bifida offspring. Q J Med 90:505-510.
38. Vollset SE, Refsum H, Irgens LM, et al. 2000. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 71:962-968. (Pubitemid 30176580)
39. Wild J, Schorah CJ, Sheldon TA, Smithells RW. 1993. Investigation of factors influencing folate status in women who have had a neural-tube defect-affected infant. Br J Obstet Gynaecol 100:546-549. (Pubitemid 23186358)
40. Williams LJ, Mai CT, Edmonds LD, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66:33-39. (Pubitemid 34734388)
41. Williams LJ, Rasmussen SA, Flores A, et al. 2005. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 116:580-586. (Pubitemid 44336670)
42. Wright ME. 1995. A case-control study of maternal nutrition and neuraltube defects in Northern Ireland. Midwifery 11:146-152.
43. Yates JRW, Ferguson-Smith MA, Shenkin A, Guzman et al. 1987. Is disordered folate metabolism the basis for the genetic predisposition to neural-tube defects? Clin Genet 31:279-287.
44. Zhao W, Mosley BS, Cleves MA, et al. 2006. Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Res A Clin Mol Teratol 76:230-236.
45. Zhu HP, Wicker NJ, Shaw GM, et al. 2003. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 78:216-221. (Pubitemid 36332023)